Joseph Michael Fitzgerald, EVP & President, Interven Cardio at BOSTON SCIENTIFIC CORP (BSX), sold 155,280 shares at $40.76 ($6.3M) on 2020-09-11, disclosed to the SEC on 2020-09-14.
Open-market sale of $6.3M BSX by EVP & President, Interven Cardio. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $40.76 | 77,640 | $3.2M | 50.0% |
| 2 | $40.76 | 77,640 | $3.2M | 50.0% |
| Total | $40.76 avg | 155,280 | $6.3M | 100% |
| Filing → |
| BSX | SELL | 2025-09-03 | $10.5M | — | Filing → |
| BSX | SELL | 2025-08-04 | $5.2M | — | Filing → |
| BSX | SELL | 2025-07-02 | $5.3M | — | Filing → |